Cutler Group LP Pacific Biosciences Of California, Inc. Put Options Transaction History

Cutler Group LP

11 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2023 Jan 18, 2024	BUY	$5.97 - $10.36 $48,954 - $84,952	8,200 Added 512.5%	9,800 $0
Q1 2023 May 01, 2023	SELL	$7.94 - $12.02 $197,706 - $299,298	-24,900 Reduced 93.96%	1,600 $0
Q4 2022 Feb 07, 2023	SELL	$5.67 - $11.2 $209,790 - $414,400	-37,000 Reduced 58.27%	26,500 $52,000
Q3 2022 Oct 25, 2022	BUY	$3.93 - $8.57 $207,111 - $451,639	52,700 Added 487.96%	63,500 $96,000
Q2 2022 Aug 04, 2022	SELL	$4.02 - $10.43 $16,482 - $42,763	-4,100 Reduced 27.52%	10,800 $88,000
Q1 2022 Apr 14, 2022	SELL	$8.43 - $20.9 $843 - $2,090	-100 Reduced 0.67%	14,900 $57,000
Q4 2021 Jan 18, 2022	BUY	$19.26 - $30.08 $3,852 - $6,016	200 Added 1.35%	15,000 $38,000
Q3 2021 Oct 26, 2021	SELL	$24.86 - $35.02 $631,444 - $889,508	-25,400 Reduced 63.18%	14,800 $53,000
Q2 2021 Jul 19, 2021	SELL	$22.3 - $36.02 $98,120 - $158,488	-4,400 Reduced 9.87%	40,200 $66,000
Q1 2021 Apr 26, 2021	BUY	$26.38 - $51.15 $553,980 - $1.07 Million	21,000 Added 88.98%	44,600 $203,000
Q4 2020 Jan 21, 2021	BUY	$10.5 - $28.5 $247,800 - $672,600	23,600 New	23,600 $18,000

254

228M

745K

1.23M

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $438M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.